API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/01/24/2815109/0/en/Theratechnologies-Receives-Complete-Response-Letter-CRL-from-the-FDA-for-the-F8-Formulation-of-Tesamorelin-sBLA.html
https://www.globenewswire.com//news-release/2024/01/23/2813983/0/en/Theratechnologies-Receives-Update-from-FDA-on-Tesamorelin-F8-Supplemental-Biologic-License-Application.html
https://www.globenewswire.com//news-release/2023/10/04/2754473/0/en/Theratechnologies-Receives-January-2024-PDUFA-Goal-Date-for-Tesamorelin-F8-Formulation-sBLA.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-14-2018-1542217134.pdf